Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 93 entries
Sorted by: Best Match Show Resources per page
Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

Nature communications

Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, Guo Q, Schmidt MK, Shah M, Luben R, Brown J, Czene K, Darabi H, Eriksson M, Klevebring D, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Thienpont B, Neven P, Wildiers H, Broeks A, Van't Veer LJ, Rutgers EJT, Couch FJ, Olson JE, Hallberg E, Vachon C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Peto J, Dos-Santos-Silva I, Gibson L, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Hall P, Li J, Liu J, Humphreys K, Kang D, Choi JY, Park SK, Noh DY, Matsuo K, Ito H, Iwata H, Yatabe Y, Guénel P, Truong T, Menegaux F, Sanchez M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Benitez J, Pilar Zamora M, Perez JIA, Menéndez P, Shu XO, Lu W, Gao YT, Cai Q, Cox A, Cross SS, Reed MWR, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Lindblom A, Margolin S, Teo SH, Yip CH, Lee DSC, Wong TY, Hooning MJ, Martens JWM, Collée JM, van Deurzen CHM, Hopper JL, Southey MC, Tsimiklis H, Kapuscinski MK, Shen CY, Wu PE, Yu JC, Chen ST, Alnæs GG, Borresen-Dale AL, Giles GG, Milne RL, McLean C, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Hartman M, Miao H, Buhari SABS, Teo YY, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, García-Closas M, Figueroa J, Chanock SJ, Lissowska J, Simard J, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Brauch H, Brüning T, Koto YD, Radice P, Peterlongo P, Bonanni B, Volorio S, Dörk T, Bogdanova NV, Helbig S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Tollenaar RAEM, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Hamann U, Torres D, Zheng W, Long J, Anton-Culver H, Neuhausen SL, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, González-Neira A, Pita G, Rosario Alonso M, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, de Santiago I, Carroll J, Caldas C, Brown MA, Lupien M, Kristensen VN, Pharoah PDP, Chenevix-Trench G, French JD, Easton DF, Dunning AM.
PMID: 29633761
Nat Commun. 2018 Apr 10;9:16193. doi: 10.1038/ncomms16193.

This corrects the article DOI: 10.1038/ncomms5999.

Cite
Ghoussaini M, Edwards SL, Michailidou K, et al. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nat Commun. 2018;9:16193doi: 10.1038/ncomms16193.
Ghoussaini, M., Edwards, S. L., Michailidou, K., Nord, S., Cowper-Sal Lari, R., Desai, K., Kar, S., Hillman, K. M., Kaufmann, S., Glubb, D. M., Beesley, J., Dennis, J., Bolla, M. K., Wang, Q., Dicks, E., Guo, Q., Schmidt, M. K., Shah, M., Luben, R., Brown, J., Czene, K., Darabi, H., Eriksson, M., Klevebring, D., Bojesen, S. E., Nordestgaard, B. G., Nielsen, S. F., Flyger, H., Lambrechts, D., Thienpont, B., Neven, P., Wildiers, H., Broeks, A., Van't Veer, L. J., Rutgers, E. J. T., Couch, F. J., Olson, J. E., Hallberg, E., Vachon, C., Chang-Claude, J., Rudolph, A., Seibold, P., Flesch-Janys, D., Peto, J., Dos-Santos-Silva, I., Gibson, L., Nevanlinna, H., Muranen, T. A., Aittomäki, K., Blomqvist, C., Hall, P., Li, J., Liu, J., Humphreys, K., Kang, D., Choi, J. Y., Park, S. K., Noh, D. Y., Matsuo, K., Ito, H., Iwata, H., Yatabe, Y., Guénel, P., Truong, T., Menegaux, F., Sanchez, M., Burwinkel, B., Marme, F., Schneeweiss, A., Sohn, C., Wu, A. H., Tseng, C. C., Van Den Berg, D., Stram, D. O., Benitez, J., Pilar Zamora, M., Perez, J. I. A., Menéndez, P., Shu, X. O., Lu, W., Gao, Y. T., Cai, Q., Cox, A., Cross, S. S., Reed, M. W. R., Andrulis, I. L., Knight, J. A., Glendon, G., Tchatchou, S., Sawyer, E. J., Tomlinson, I., Kerin, M. J., Miller, N., Haiman, C. A., Henderson, B. E., Schumacher, F., Le Marchand, L., Lindblom, A., Margolin, S., Teo, S. H., Yip, C. H., Lee, D. S. C., Wong, T. Y., Hooning, M. J., Martens, J. W. M., Collée, J. M., van Deurzen, C. H. M., Hopper, J. L., Southey, M. C., Tsimiklis, H., Kapuscinski, M. K., Shen, C. Y., Wu, P. E., Yu, J. C., Chen, S. T., Alnæs, G. G., Borresen-Dale, A. L., Giles, G. G., Milne, R. L., McLean, C., Muir, K., Lophatananon, A., Stewart-Brown, S., Siriwanarangsan, P., Hartman, M., Miao, H., Buhari, S. A. B. S., Teo, Y. Y., Fasching, P. A., Haeberle, L., Ekici, A. B., Beckmann, M. W., Brenner, H., Dieffenbach, A. K., Arndt, V., Stegmaier, C., Swerdlow, A., Ashworth, A., Orr, N., Schoemaker, M. J., García-Closas, M., Figueroa, J., Chanock, S. J., Lissowska, J., Simard, J., Goldberg, M. S., Labrèche, F., Dumont, M., Winqvist, R., Pylkäs, K., Jukkola-Vuorinen, A., Brauch, H., Brüning, T., Koto, Y. D., Radice, P., Peterlongo, P., Bonanni, B., Volorio, S., Dörk, T., Bogdanova, N. V., Helbig, S., Mannermaa, A., Kataja, V., Kosma, V. M., Hartikainen, J. M., Devilee, P., Tollenaar, R. A. E. M., Seynaeve, C., Van Asperen, C. J., Jakubowska, A., Lubinski, J., Jaworska-Bieniek, K., Durda, K., Slager, S., Toland, A. E., Ambrosone, C. B., Yannoukakos, D., Sangrajrang, S., Gaborieau, V., Brennan, P., McKay, J., Hamann, U., Torres, D., Zheng, W., Long, J., Anton-Culver, H., Neuhausen, S. L., Luccarini, C., Baynes, C., Ahmed, S., Maranian, M., Healey, C. S., González-Neira, A., Pita, G., Rosario Alonso, M., Álvarez, N., Herrero, D., Tessier, D. C., Vincent, D., Bacot, F., de Santiago, I., Carroll, J., Caldas, C., Brown, M. A., Lupien, M., Kristensen, V. N., Pharoah, P. D. P., Chenevix-Trench, G., French, J. D., Easton, D. F., & Dunning, A. M. (2018). Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nature communications, 916193. https://doi.org/10.1038/ncomms16193
Ghoussaini, Maya, et al. "Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation." Nature communications vol. 9 (2018): 16193. doi: https://doi.org/10.1038/ncomms16193
Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, Guo Q, Schmidt MK, Shah M, Luben R, Brown J, Czene K, Darabi H, Eriksson M, Klevebring D, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Thienpont B, Neven P, Wildiers H, Broeks A, Van't Veer LJ, Rutgers EJT, Couch FJ, Olson JE, Hallberg E, Vachon C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Peto J, Dos-Santos-Silva I, Gibson L, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Hall P, Li J, Liu J, Humphreys K, Kang D, Choi JY, Park SK, Noh DY, Matsuo K, Ito H, Iwata H, Yatabe Y, Guénel P, Truong T, Menegaux F, Sanchez M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Benitez J, Pilar Zamora M, Perez JIA, Menéndez P, Shu XO, Lu W, Gao YT, Cai Q, Cox A, Cross SS, Reed MWR, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Lindblom A, Margolin S, Teo SH, Yip CH, Lee DSC, Wong TY, Hooning MJ, Martens JWM, Collée JM, van Deurzen CHM, Hopper JL, Southey MC, Tsimiklis H, Kapuscinski MK, Shen CY, Wu PE, Yu JC, Chen ST, Alnæs GG, Borresen-Dale AL, Giles GG, Milne RL, McLean C, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Hartman M, Miao H, Buhari SABS, Teo YY, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, García-Closas M, Figueroa J, Chanock SJ, Lissowska J, Simard J, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Brauch H, Brüning T, Koto YD, Radice P, Peterlongo P, Bonanni B, Volorio S, Dörk T, Bogdanova NV, Helbig S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Tollenaar RAEM, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Hamann U, Torres D, Zheng W, Long J, Anton-Culver H, Neuhausen SL, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, González-Neira A, Pita G, Rosario Alonso M, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, de Santiago I, Carroll J, Caldas C, Brown MA, Lupien M, Kristensen VN, Pharoah PDP, Chenevix-Trench G, French JD, Easton DF, Dunning AM. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nat Commun. 2018 Apr 10;9:16193. doi: 10.1038/ncomms16193. PMID: 29633761; PMCID: PMC5898457.
Copy Download .nbib Format: NLM
Enhanced charge transfer to molecular ions by electronic excitation of the target.

Physical review. A, Atomic, molecular, and optical physics

Bruckmeier R, Figger H, Wunderlich C.
PMID: 9912251
Phys Rev A. 1995 Jul;52(1):334-341. doi: 10.1103/physreva.52.334.

No abstract available.

Cite
Bruckmeier R, Figger H, Wunderlich C. Enhanced charge transfer to molecular ions by electronic excitation of the target. Phys Rev A. 1995;52(1):334-341doi: 10.1103/physreva.52.334.
Bruckmeier, R., Figger, H., & Wunderlich, C. (1995). Enhanced charge transfer to molecular ions by electronic excitation of the target. Physical review. A, Atomic, molecular, and optical physics, 52(1), 334-341. https://doi.org/10.1103/physreva.52.334
Bruckmeier, et al. "Enhanced charge transfer to molecular ions by electronic excitation of the target." Physical review. A, Atomic, molecular, and optical physics vol. 52,1 (1995): 334-341. doi: https://doi.org/10.1103/physreva.52.334
Bruckmeier R, Figger H, Wunderlich C. Enhanced charge transfer to molecular ions by electronic excitation of the target. Phys Rev A. 1995 Jul;52(1):334-341. doi: 10.1103/physreva.52.334. PMID: 9912251.
Copy Download .nbib Format: NLM
Alpha decay of 186Pb and 184Hg: The influence of mixing of 0(+) states on alpha -decay transition probabilities.

Physical review. C, Nuclear physics

Bijnens N, Folger H, Huyse M, Hwang HY, Kirchner R, Van Duppen P, von Schwarzenberg J, Wauters J.
PMID: 9969974
Phys Rev C Nucl Phys. 1994 Dec;50(6):2768-2773. doi: 10.1103/physrevc.50.2768.

No abstract available.

Cite
Bijnens N, Folger H, Huyse M, et al. Alpha decay of 186Pb and 184Hg: The influence of mixing of 0(+) states on alpha -decay transition probabilities. Phys Rev C Nucl Phys. 1994;50(6):2768-2773doi: 10.1103/physrevc.50.2768.
Bijnens, N., Folger, H., Huyse, M., Hwang, H. Y., Kirchner, R., Van Duppen P, von Schwarzenberg J, & Wauters, J. (1994). Alpha decay of 186Pb and 184Hg: The influence of mixing of 0(+) states on alpha -decay transition probabilities. Physical review. C, Nuclear physics, 50(6), 2768-2773. https://doi.org/10.1103/physrevc.50.2768
Bijnens, et al. "Alpha decay of 186Pb and 184Hg: The influence of mixing of 0(+) states on alpha -decay transition probabilities." Physical review. C, Nuclear physics vol. 50,6 (1994): 2768-2773. doi: https://doi.org/10.1103/physrevc.50.2768
Bijnens N, Folger H, Huyse M, Hwang HY, Kirchner R, Van Duppen P, von Schwarzenberg J, Wauters J. Alpha decay of 186Pb and 184Hg: The influence of mixing of 0(+) states on alpha -decay transition probabilities. Phys Rev C Nucl Phys. 1994 Dec;50(6):2768-2773. doi: 10.1103/physrevc.50.2768. PMID: 9969974.
Copy Download .nbib Format: NLM
CheckMate-067: Raising the Bar for the Next Decade in Oncology.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Weiss SA, Kluger H.
PMID: 34855466
J Clin Oncol. 2021 Dec 02;JCO2102549. doi: 10.1200/JCO.21.02549. Epub 2021 Dec 02.

No abstract available.

Cite
Weiss SA, Kluger H. CheckMate-067: Raising the Bar for the Next Decade in Oncology. J Clin Oncol. 2021;JCO2102549doi: 10.1200/JCO.21.02549.
Weiss, S. A., & Kluger, H. (2021). CheckMate-067: Raising the Bar for the Next Decade in Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, JCO2102549. https://doi.org/10.1200/JCO.21.02549
Weiss, Sarah A, and Kluger, Harriet. "CheckMate-067: Raising the Bar for the Next Decade in Oncology." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. (2021): JCO2102549. doi: https://doi.org/10.1200/JCO.21.02549
Weiss SA, Kluger H. CheckMate-067: Raising the Bar for the Next Decade in Oncology. J Clin Oncol. 2021 Dec 02;JCO2102549. doi: 10.1200/JCO.21.02549. Epub 2021 Dec 02. PMID: 34855466; PMCID: PMC8718180.
Copy Download .nbib Format: NLM
CheckMate-067: Raising the Bar for the Next Decade in Oncology.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Weiss SA, Kluger H.
PMID: 34855466
J Clin Oncol. 2021 Dec 02;JCO2102549. doi: 10.1200/JCO.21.02549. Epub 2021 Dec 02.

No abstract available.

Cite
Weiss SA, Kluger H. CheckMate-067: Raising the Bar for the Next Decade in Oncology. J Clin Oncol. 2021;JCO2102549doi: 10.1200/JCO.21.02549.
Weiss, S. A., & Kluger, H. (2021). CheckMate-067: Raising the Bar for the Next Decade in Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, JCO2102549. https://doi.org/10.1200/JCO.21.02549
Weiss, Sarah A, and Kluger, Harriet. "CheckMate-067: Raising the Bar for the Next Decade in Oncology." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. (2021): JCO2102549. doi: https://doi.org/10.1200/JCO.21.02549
Weiss SA, Kluger H. CheckMate-067: Raising the Bar for the Next Decade in Oncology. J Clin Oncol. 2021 Dec 02;JCO2102549. doi: 10.1200/JCO.21.02549. Epub 2021 Dec 02. PMID: 34855466; PMCID: PMC8718180.
Copy Download .nbib Format: NLM
CheckMate-067: Raising the Bar for the Next Decade in Oncology.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Weiss SA, Kluger H.
PMID: 34855466
J Clin Oncol. 2021 Dec 02;JCO2102549. doi: 10.1200/JCO.21.02549. Epub 2021 Dec 02.

No abstract available.

Cite
Weiss SA, Kluger H. CheckMate-067: Raising the Bar for the Next Decade in Oncology. J Clin Oncol. 2021;JCO2102549doi: 10.1200/JCO.21.02549.
Weiss, S. A., & Kluger, H. (2021). CheckMate-067: Raising the Bar for the Next Decade in Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, JCO2102549. https://doi.org/10.1200/JCO.21.02549
Weiss, Sarah A, and Kluger, Harriet. "CheckMate-067: Raising the Bar for the Next Decade in Oncology." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. (2021): JCO2102549. doi: https://doi.org/10.1200/JCO.21.02549
Weiss SA, Kluger H. CheckMate-067: Raising the Bar for the Next Decade in Oncology. J Clin Oncol. 2021 Dec 02;JCO2102549. doi: 10.1200/JCO.21.02549. Epub 2021 Dec 02. PMID: 34855466.
Copy Download .nbib Format: NLM
In Regard to Polgar et al.

International journal of radiation oncology, biology, physics

Vaidya JS, Bulsara M, Sperk E, Massarut S, Douek M, Alvarado M, Pigorsch S, Holmes D, Bernstein M, Saunders C, Flyger H, Joseph D, Wenz F, Tobias JS.
PMID: 33640419
Int J Radiat Oncol Biol Phys. 2021 Jul 01;110(3):905-907. doi: 10.1016/j.ijrobp.2021.01.059. Epub 2021 Feb 25.

No abstract available.

Cite
Vaidya JS, Bulsara M, Sperk E, et al. In Regard to Polgar et al. Int J Radiat Oncol Biol Phys. 2021;110(3):905-907doi: 10.1016/j.ijrobp.2021.01.059.
Vaidya, J. S., Bulsara, M., Sperk, E., Massarut, S., Douek, M., Alvarado, M., Pigorsch, S., Holmes, D., Bernstein, M., Saunders, C., Flyger, H., Joseph, D., Wenz, F., Tobias, J. S. (2021). In Regard to Polgar et al. International journal of radiation oncology, biology, physics, 110(3), 905-907. https://doi.org/10.1016/j.ijrobp.2021.01.059
Vaidya, Jayant S, et al. "In Regard to Polgar et al." International journal of radiation oncology, biology, physics vol. 110,3 (2021): 905-907. doi: https://doi.org/10.1016/j.ijrobp.2021.01.059
Vaidya JS, Bulsara M, Sperk E, Massarut S, Douek M, Alvarado M, Pigorsch S, Holmes D, Bernstein M, Saunders C, Flyger H, Joseph D, Wenz F, Tobias JS. In Regard to Polgar et al. Int J Radiat Oncol Biol Phys. 2021 Jul 01;110(3):905-907. doi: 10.1016/j.ijrobp.2021.01.059. Epub 2021 Feb 25. PMID: 33640419.
Copy Download .nbib Format: NLM
Adverse events induced by immune checkpoint inhibitors.

Current opinion in immunology

Perdigoto AL, Kluger H, Herold KC.
PMID: 33640598
Curr Opin Immunol. 2021 Apr;69:29-38. doi: 10.1016/j.coi.2021.02.002. Epub 2021 Feb 25.

Immune checkpoint inhibitors have revolutionized the treatments of cancers but are also associated with immune related adverse events that can interfere with their use. The types and severity of adverse events vary with checkpoint inhibitors. A single mechanism of...

Cite
Perdigoto AL, Kluger H, Herold KC. Adverse events induced by immune checkpoint inhibitors. Curr Opin Immunol. 2021;69:29-38doi: 10.1016/j.coi.2021.02.002.
Perdigoto, A. L., Kluger, H., & Herold, K. C. (2021). Adverse events induced by immune checkpoint inhibitors. Current opinion in immunology, 6929-38. https://doi.org/10.1016/j.coi.2021.02.002
Perdigoto, Ana Luisa, et al. "Adverse events induced by immune checkpoint inhibitors." Current opinion in immunology vol. 69 (2021): 29-38. doi: https://doi.org/10.1016/j.coi.2021.02.002
Perdigoto AL, Kluger H, Herold KC. Adverse events induced by immune checkpoint inhibitors. Curr Opin Immunol. 2021 Apr;69:29-38. doi: 10.1016/j.coi.2021.02.002. Epub 2021 Feb 25. PMID: 33640598; PMCID: PMC8122053.
Copy Download .nbib Format: NLM
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

Nature communications

Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Arnold N, Aronson KJ, Arun BK, Augustinsson A, Azzollini J, Barrowdale D, Baynes C, Becher H, Bermisheva M, Bernstein L, Białkowska K, Blomqvist C, Bojesen SE, Bonanni B, Borg A, Brauch H, Brenner H, Burwinkel B, Buys SS, Caldés T, Caligo MA, Campa D, Carter BD, Castelao JE, Chang-Claude J, Chanock SJ, Chung WK, Claes KBM, Clarke CL, Collée JM, Conroy DM, Czene K, Daly MB, Devilee P, Diez O, Ding YC, Domchek SM, Dörk T, Dos-Santos-Silva I, Dunning AM, Dwek M, Eccles DM, Eliassen AH, Engel C, Eriksson M, Evans DG, Fasching PA, Flyger H, Fostira F, Friedman E, Fritschi L, Frost D, Gago-Dominguez M, Gapstur SM, Garber J, Garcia-Barberan V, García-Closas M, García-Sáenz JA, Gaudet MM, Gayther SA, Gehrig A, Georgoulias V, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hart SN, He W, Hogervorst FBL, Hollestelle A, Hopper JL, Horcasitas DJ, Hulick PJ, Hunter DJ, Imyanitov EN, Jager A, Jakubowska A, James PA, Jensen UB, John EM, Jones ME, Kaaks R, Kapoor PM, Karlan BY, Keeman R, Khusnutdinova E, Kiiski JI, Ko YD, Kosma VM, Kraft P, Kurian AW, Laitman Y, Lambrechts D, Le Marchand L, Lester J, Lesueur F, Lindstrom T, Lopez-Fernández A, Loud JT, Luccarini C, Mannermaa A, Manoukian S, Margolin S, Martens JWM, Mebirouk N, Meindl A, Miller A, Milne RL, Montagna M, Nathanson KL, Neuhausen SL, Nevanlinna H, Nielsen FC, O'Brien KM, Olopade OI, Olson JE, Olsson H, Osorio A, Ottini L, Park-Simon TW, Parsons MT, Pedersen IS, Peshkin B, Peterlongo P, Peto J, Pharoah PDP, Phillips KA, Polley EC, Poppe B, Presneau N, Pujana MA, Punie K, Radice P, Rantala J, Rashid MU, Rennert G, Rennert HS, Robson M, Romero A, Rossing M, Saloustros E, Sandler DP, Santella R, Scheuner MT, Schmidt MK, Schmidt G, Scott C, Sharma P, Soucy P, Southey MC, Spinelli JJ, Steinsnyder Z, Stone J, Stoppa-Lyonnet D, Swerdlow A, Tamimi RM, Tapper WJ, Taylor JA, Terry MB, Teulé A, Thull DL, Tischkowitz M, Toland AE, Torres D, Trainer AH, Truong T, Tung N, Vachon CM, Vega A, Vijai J, Wang Q, Wappenschmidt B, Weinberg CR, Weitzel JN, Wendt C, Wolk A, Yadav S, Yang XR, Yannoukakos D, Zheng W, Ziogas A, Zorn KK, Park SK, Thomassen M, Offit K, Schmutzler RK, Couch FJ, Simard J, Chenevix-Trench G, Easton DF, Andrieu N, Antoniou AC.
PMID: 33990587
Nat Commun. 2021 May 14;12(1):2986. doi: 10.1038/s41467-021-23162-4.

A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-23162-4.

Cite
Coignard J, Lush M, Beesley J, et al. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021;12(1):2986doi: 10.1038/s41467-021-23162-4.
Coignard, J., Lush, M., Beesley, J., O'Mara, T. A., Dennis, J., Tyrer, J. P., Barnes, D. R., McGuffog, L., Leslie, G., Bolla, M. K., Adank, M. A., Agata, S., Ahearn, T., Aittomäki, K., Andrulis, I. L., Anton-Culver, H., Arndt, V., Arnold, N., Aronson, K. J., Arun, B. K., Augustinsson, A., Azzollini, J., Barrowdale, D., Baynes, C., Becher, H., Bermisheva, M., Bernstein, L., Białkowska, K., Blomqvist, C., Bojesen, S. E., Bonanni, B., Borg, A., Brauch, H., Brenner, H., Burwinkel, B., Buys, S. S., Caldés, T., Caligo, M. A., Campa, D., Carter, B. D., Castelao, J. E., Chang-Claude, J., Chanock, S. J., Chung, W. K., Claes, K. B. M., Clarke, C. L., Collée, J. M., Conroy, D. M., Czene, K., Daly, M. B., Devilee, P., Diez, O., Ding, Y. C., Domchek, S. M., Dörk, T., Dos-Santos-Silva, I., Dunning, A. M., Dwek, M., Eccles, D. M., Eliassen, A. H., Engel, C., Eriksson, M., Evans, D. G., Fasching, P. A., Flyger, H., Fostira, F., Friedman, E., Fritschi, L., Frost, D., Gago-Dominguez, M., Gapstur, S. M., Garber, J., Garcia-Barberan, V., García-Closas, M., García-Sáenz, J. A., Gaudet, M. M., Gayther, S. A., Gehrig, A., Georgoulias, V., Giles, G. G., Godwin, A. K., Goldberg, M. S., Goldgar, D. E., González-Neira, A., Greene, M. H., Guénel, P., Haeberle, L., Hahnen, E., Haiman, C. A., Håkansson, N., Hall, P., Hamann, U., Harrington, P. A., Hart, S. N., He, W., Hogervorst, F. B. L., Hollestelle, A., Hopper, J. L., Horcasitas, D. J., Hulick, P. J., Hunter, D. J., Imyanitov, E. N., Jager, A., Jakubowska, A., James, P. A., Jensen, U. B., John, E. M., Jones, M. E., Kaaks, R., Kapoor, P. M., Karlan, B. Y., Keeman, R., Khusnutdinova, E., Kiiski, J. I., Ko, Y. D., Kosma, V. M., Kraft, P., Kurian, A. W., Laitman, Y., Lambrechts, D., Le Marchand, L., Lester, J., Lesueur, F., Lindstrom, T., Lopez-Fernández, A., Loud, J. T., Luccarini, C., Mannermaa, A., Manoukian, S., Margolin, S., Martens, J. W. M., Mebirouk, N., Meindl, A., Miller, A., Milne, R. L., Montagna, M., Nathanson, K. L., Neuhausen, S. L., Nevanlinna, H., Nielsen, F. C., O'Brien, K. M., Olopade, O. I., Olson, J. E., Olsson, H., Osorio, A., Ottini, L., Park-Simon, T. W., Parsons, M. T., Pedersen, I. S., Peshkin, B., Peterlongo, P., Peto, J., Pharoah, P. D. P., Phillips, K. A., Polley, E. C., Poppe, B., Presneau, N., Pujana, M. A., Punie, K., Radice, P., Rantala, J., Rashid, M. U., Rennert, G., Rennert, H. S., Robson, M., Romero, A., Rossing, M., Saloustros, E., Sandler, D. P., Santella, R., Scheuner, M. T., Schmidt, M. K., Schmidt, G., Scott, C., Sharma, P., Soucy, P., Southey, M. C., Spinelli, J. J., Steinsnyder, Z., Stone, J., Stoppa-Lyonnet, D., Swerdlow, A., Tamimi, R. M., Tapper, W. J., Taylor, J. A., Terry, M. B., Teulé, A., Thull, D. L., Tischkowitz, M., Toland, A. E., Torres, D., Trainer, A. H., Truong, T., Tung, N., Vachon, C. M., Vega, A., Vijai, J., Wang, Q., Wappenschmidt, B., Weinberg, C. R., Weitzel, J. N., Wendt, C., Wolk, A., Yadav, S., Yang, X. R., Yannoukakos, D., Zheng, W., Ziogas, A., Zorn, K. K., Park, S. K., Thomassen, M., Offit, K., Schmutzler, R. K., Couch, F. J., Simard, J., Chenevix-Trench, G., Easton, D. F., Andrieu, N., & Antoniou, A. C. (2021). Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature communications, 12(1), 2986. https://doi.org/10.1038/s41467-021-23162-4
Coignard, Juliette, et al. "Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers." Nature communications vol. 12,1 (2021): 2986. doi: https://doi.org/10.1038/s41467-021-23162-4
Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Arnold N, Aronson KJ, Arun BK, Augustinsson A, Azzollini J, Barrowdale D, Baynes C, Becher H, Bermisheva M, Bernstein L, Białkowska K, Blomqvist C, Bojesen SE, Bonanni B, Borg A, Brauch H, Brenner H, Burwinkel B, Buys SS, Caldés T, Caligo MA, Campa D, Carter BD, Castelao JE, Chang-Claude J, Chanock SJ, Chung WK, Claes KBM, Clarke CL, Collée JM, Conroy DM, Czene K, Daly MB, Devilee P, Diez O, Ding YC, Domchek SM, Dörk T, Dos-Santos-Silva I, Dunning AM, Dwek M, Eccles DM, Eliassen AH, Engel C, Eriksson M, Evans DG, Fasching PA, Flyger H, Fostira F, Friedman E, Fritschi L, Frost D, Gago-Dominguez M, Gapstur SM, Garber J, Garcia-Barberan V, García-Closas M, García-Sáenz JA, Gaudet MM, Gayther SA, Gehrig A, Georgoulias V, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hart SN, He W, Hogervorst FBL, Hollestelle A, Hopper JL, Horcasitas DJ, Hulick PJ, Hunter DJ, Imyanitov EN, Jager A, Jakubowska A, James PA, Jensen UB, John EM, Jones ME, Kaaks R, Kapoor PM, Karlan BY, Keeman R, Khusnutdinova E, Kiiski JI, Ko YD, Kosma VM, Kraft P, Kurian AW, Laitman Y, Lambrechts D, Le Marchand L, Lester J, Lesueur F, Lindstrom T, Lopez-Fernández A, Loud JT, Luccarini C, Mannermaa A, Manoukian S, Margolin S, Martens JWM, Mebirouk N, Meindl A, Miller A, Milne RL, Montagna M, Nathanson KL, Neuhausen SL, Nevanlinna H, Nielsen FC, O'Brien KM, Olopade OI, Olson JE, Olsson H, Osorio A, Ottini L, Park-Simon TW, Parsons MT, Pedersen IS, Peshkin B, Peterlongo P, Peto J, Pharoah PDP, Phillips KA, Polley EC, Poppe B, Presneau N, Pujana MA, Punie K, Radice P, Rantala J, Rashid MU, Rennert G, Rennert HS, Robson M, Romero A, Rossing M, Saloustros E, Sandler DP, Santella R, Scheuner MT, Schmidt MK, Schmidt G, Scott C, Sharma P, Soucy P, Southey MC, Spinelli JJ, Steinsnyder Z, Stone J, Stoppa-Lyonnet D, Swerdlow A, Tamimi RM, Tapper WJ, Taylor JA, Terry MB, Teulé A, Thull DL, Tischkowitz M, Toland AE, Torres D, Trainer AH, Truong T, Tung N, Vachon CM, Vega A, Vijai J, Wang Q, Wappenschmidt B, Weinberg CR, Weitzel JN, Wendt C, Wolk A, Yadav S, Yang XR, Yannoukakos D, Zheng W, Ziogas A, Zorn KK, Park SK, Thomassen M, Offit K, Schmutzler RK, Couch FJ, Simard J, Chenevix-Trench G, Easton DF, Andrieu N, Antoniou AC. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021 May 14;12(1):2986. doi: 10.1038/s41467-021-23162-4. PMID: 33990587; PMCID: PMC8121813.
Copy Download .nbib Format: NLM
Merkel Cell Carcinoma: Changing Practice Patterns and Impact on Recurrence-Free and Overall Survival at a Single Institution and Nationally.

Annals of surgical oncology

Esposito A, Jacobs D, Ariyan S, Galan A, Kluger H, Clune J, Weiss S, Tran T, Olino K.
PMID: 34494169
Ann Surg Oncol. 2022 Jan;29(1):415-424. doi: 10.1245/s10434-021-10727-2. Epub 2021 Sep 07.

BACKGROUND: Merkel cell carcinoma (MCC) is an aggressive neuroendocrine carcinoma of the skin. Our report describes the evolution of management and characteristics associated with recurrence, disease-specific survival (DSS) and overall survival (OS) in the treatment of MCC.METHODS: A single...

Cite
Esposito A, Jacobs D, Ariyan S, et al. Merkel Cell Carcinoma: Changing Practice Patterns and Impact on Recurrence-Free and Overall Survival at a Single Institution and Nationally. Ann Surg Oncol. 2021;29(1):415-424doi: 10.1245/s10434-021-10727-2.
Esposito, A., Jacobs, D., Ariyan, S., Galan, A., Kluger, H., Clune, J., Weiss, S., Tran, T., & Olino, K. (2022). Merkel Cell Carcinoma: Changing Practice Patterns and Impact on Recurrence-Free and Overall Survival at a Single Institution and Nationally. Annals of surgical oncology, 29(1), 415-424. https://doi.org/10.1245/s10434-021-10727-2
Esposito, Andrew, et al. "Merkel Cell Carcinoma: Changing Practice Patterns and Impact on Recurrence-Free and Overall Survival at a Single Institution and Nationally." Annals of surgical oncology vol. 29,1 (2022): 415-424. doi: https://doi.org/10.1245/s10434-021-10727-2
Esposito A, Jacobs D, Ariyan S, Galan A, Kluger H, Clune J, Weiss S, Tran T, Olino K. Merkel Cell Carcinoma: Changing Practice Patterns and Impact on Recurrence-Free and Overall Survival at a Single Institution and Nationally. Ann Surg Oncol. 2022 Jan;29(1):415-424. doi: 10.1245/s10434-021-10727-2. Epub 2021 Sep 07. PMID: 34494169.
Copy Download .nbib Format: NLM
Cardiac Biventricular Metastasis From Renal Cell Carcinoma.

Cureus

Latifi AN, Ibe U, Arbune A, Kluger H, Baldassarre LA.
PMID: 33178523
Cureus. 2020 Oct 09;12(10):e10870. doi: 10.7759/cureus.10870.

Secondary cardiac tumors are much more common than primary tumors. Cardiac metastases from renal cell carcinoma (RCC) are rare and can present many years after the patient has been disease-free. We report the case of a 64-year-old man who...

Cite
Latifi AN, Ibe U, Arbune A, et al. Cardiac Biventricular Metastasis From Renal Cell Carcinoma. Cureus. 2020;12(10):e10870doi: 10.7759/cureus.10870.
Latifi, A. N., Ibe, U., Arbune, A., Kluger, H., & Baldassarre, L. A. (2020). Cardiac Biventricular Metastasis From Renal Cell Carcinoma. Cureus, 12(10), e10870. https://doi.org/10.7759/cureus.10870
Latifi, Ahmad Nawid, et al. "Cardiac Biventricular Metastasis From Renal Cell Carcinoma." Cureus vol. 12,10 (2020): e10870. doi: https://doi.org/10.7759/cureus.10870
Latifi AN, Ibe U, Arbune A, Kluger H, Baldassarre LA. Cardiac Biventricular Metastasis From Renal Cell Carcinoma. Cureus. 2020 Oct 09;12(10):e10870. doi: 10.7759/cureus.10870. PMID: 33178523; PMCID: PMC7652367.
Copy Download .nbib Format: NLM
[Off-label use in cardiac surgery].

Zeitschrift fur Herz-, Thorax- und Gefasschirurgie

Fenger H, Löher A, Sindermann JR, Scheld HH, Schmidt C, Hoffmeier A.
PMID: 32288286
Z Herz Thorax Gefasschir. 2009;23(6):345-348. doi: 10.1007/s00398-009-0732-y. Epub 2009 Jul 22.

In the view of off-label use, special concern should be granted to obtaining informed consent from the patient. It is important to point out the test character of the treatment. The patient has to be informed about the risks...

Cite
Fenger H, Löher A, Sindermann JR, et al. „Off-label use“ in der Herzchirurgie. [Off-label use in cardiac surgery]. Z Herz Thorax Gefasschir. 2009;23(6):345-348doi: 10.1007/s00398-009-0732-y.
Fenger, H., Löher, A., Sindermann, J. R., Scheld, H. H., Schmidt, C., & Hoffmeier, A. (2009). „Off-label use“ in der Herzchirurgie. [Off-label use in cardiac surgery]. Zeitschrift fur Herz-, Thorax- und Gefasschirurgie, 23(6), 345-348. https://doi.org/10.1007/s00398-009-0732-y
Fenger, H, et al. "„Off-label use“ in der Herzchirurgie." [Off-label use in cardiac surgery]. Zeitschrift fur Herz-, Thorax- und Gefasschirurgie vol. 23,6 (2009): 345-348. doi: https://doi.org/10.1007/s00398-009-0732-y
Fenger H, Löher A, Sindermann JR, Scheld HH, Schmidt C, Hoffmeier A. „Off-label use“ in der Herzchirurgie. [Off-label use in cardiac surgery]. Z Herz Thorax Gefasschir. 2009;23(6):345-348. doi: 10.1007/s00398-009-0732-y. Epub 2009 Jul 22. German. PMID: 32288286; PMCID: PMC7102367.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 93 entries